Earlier, in unrelated research, we have used DBK to monitor the serum activity of ACE and basic carboxypeptidases N and B2 (CPN, CPB2) in two clinical studies on Complex-Regional Pain Syndrome and COVID-19 [64,65,66]. This evidence concerns the gene CPB2 and COVID-19.